Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -15.32% is 53% above its 5-year average of -32.49%, near the high end of its 5-year range (-47.93%–-11.83%).
51.52% above its 12-month average of -31.60%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -2.17%.
RETURN ON ASSETS (ROA)
-15.32%
RETURN ON ASSETS (ROA) AVG TTM
-31.60%
RETURN ON ASSETS (ROA) AVG 3Y
-39.35%
RETURN ON ASSETS (ROA) AVG 5Y
-32.49%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+51.52%
CURRENT VS 3Y AVG
+61.07%
CURRENT VS 5Y AVG
+52.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+52.52%
vs the sector median at left
Instil Bio, Inc.
Market Cap
$46.69M
Return on Assets (ROA)
-15.32%
TTM Avg
-31.60%
3Y Avg
-39.35%
5Y Avg
-32.49%
Market Cap
$45.73M
Return on Assets (ROA)
-71.66%
TTM Avg
-64.58%
3Y Avg
-65.51%
5Y Avg
-55.75%
Market Cap
$47.98M
Return on Assets (ROA)
-166.66%
TTM Avg
-126.93%
3Y Avg
-59.31%
5Y Avg
-48.60%
Market Cap
$48.53M
Return on Assets (ROA)
-162.93%
TTM Avg
-287.06%
3Y Avg
-300.16%
5Y Avg
-220.25%
Market Cap
$44.72M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
Market Cap
$44.71M
Return on Assets (ROA)
39.10%
TTM Avg
-36.27%
3Y Avg
-59.86%
5Y Avg
-86.70%
Market Cap
$48.76M
Return on Assets (ROA)
-22.27%
TTM Avg
-102.93%
3Y Avg
-118.23%
5Y Avg
-95.88%
Market Cap
$48.77M
Return on Assets (ROA)
-68.93%
TTM Avg
-45.51%
3Y Avg
-54.02%
5Y Avg
-50.43%
Market Cap
$48.89M
Return on Assets (ROA)
-37.53%
TTM Avg
-1.93%
3Y Avg
9.94%
5Y Avg
4.69%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Instil Bio, Inc. (TIL) | $46.69M | -15.32% | -31.60% | -39.35% | -32.49% |
| Celularity Inc. (CELU)vs › | $45.73M | -71.66% | -64.58% | -65.51% | -55.75% |
| Lite Strategy, Inc. (LITS)vs › | $47.98M | -166.66% | -126.93% | -59.31% | -48.60% |
| Apollomics, Inc. (APLM)vs › | $48.53M | -162.93% | -287.06% | -300.16% | -220.25% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | -143.30% | -71.59% | -49.53% | -40.25% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 39.10% | -36.27% | -59.86% | -86.70% |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | -22.27% | -102.93% | -118.23% | -95.88% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | -68.93% | -45.51% | -54.02% | -50.43% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | -37.53% | -1.93% | 9.94% | 4.69% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -11.23% | -20.22% | -14.66% | -10.97% |
ROA
-15.3%
ROE
-28.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -35.07% |
| 2024-12-31 | -28.13% |
| 2023-12-31 | -47.93% |
| 2022-12-31 | -46.29% |
| 2021-12-31 | -25.70% |
| 2020-12-31 | -11.83% |
| 2019-12-31 | -68.11% |
